ACADIA PHARMACEUTICALS INC (ACAD) Shareholders’ equity 2016–2025
ACADIA PHARMACEUTICALS INC (ACAD) shareholders’ equity at each fiscal year-end, per SEC filings.
$1.2BFY2025 · since FY2016: $518.4M → $1.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.2B | +67.5% |
| FY2024 | $732.8M | +69.7% |
| FY2023 | $431.8M | +7.8% |
| FY2022 | $400.4M | -26.0% |
| FY2021 | $540.9M | -13.7% |
| FY2020 | $627.0M | -10.3% |
| FY2019 | $699.1M | +45.9% |
| FY2018 | $479.1M | +42.9% |
| FY2017 | $335.3M | -35.3% |
| FY2016 | $518.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice